Hyperarch Fascia Training for Ankle Injury
Trial Summary
What is the purpose of this trial?
The purpose of this clinical trial is to evaluate whether the Hyperarch Fascia Training (HFT) program can reduce ankle pain and improve jump performance in active adults aged 20-45 with a history of ankle sprains. Participants will be randomly assigned to either an HFT intervention group or a control group, maintaining regular activity. Over 12 weeks, participants will complete remote training sessions, track jump performance using the "My Jump Lab" app, and complete ankle pain and stability questionnaires. All activities and assessments will be conducted remotely with guidance from certified coaches.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are using certain supplements or medications like glucosamine, chondroitin, or metformin. It's best to discuss your specific medications with the trial organizers.
What data supports the effectiveness of the treatment Hyperarch Fascia Training for ankle injury?
Research shows that fascial therapy, which is a component of Hyperarch Fascia Training, can improve ankle range of motion, reduce pain, and enhance stability in individuals with ankle injuries. Additionally, fascial manipulation has been effective in preventing further ankle injuries and improving symptoms in athletes with chronic ankle instability.12345
Is Hyperarch Fascia Training safe for humans?
How does Hyperarch Fascia Training differ from other treatments for ankle injuries?
Hyperarch Fascia Training is unique because it focuses on manipulating the fascia (connective tissue) to improve ankle stability, range of motion, and reduce pain, unlike traditional treatments that may rely more on bracing or standard exercises. This approach is similar to Fascial Manipulation, which has shown effectiveness in preventing injuries and improving symptoms in athletes with chronic ankle instability.12349
Research Team
Jacob Wilson, PhD
Principal Investigator
Applied Science & Performance Institute
Eligibility Criteria
This trial is for active adults aged 20-45 who have experienced ankle sprains. They should be interested in trying a new training program to potentially reduce ankle pain and improve jump performance. Participants must be able to complete remote training sessions and assessments.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 12-week Hyperarch Fascia Training (HFT) program or maintain usual activities in the control group
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Hyperarch Fascia Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Applied Science & Performance Institute
Lead Sponsor